Polidocanol 3% Concentration Dilution for Varicose Veins
Polidocanol 3% should NOT be diluted for varicose vein treatment—it is used at full strength for larger reticular veins and saphenous vein sclerotherapy, while smaller veins require lower concentrations (0.5-1%) without dilution. 1
Concentration Selection Based on Vein Size
The FDA-approved dosing strategy is straightforward and concentration-dependent on vessel diameter:
- Spider veins (≤1 mm diameter): Use 0.5% polidocanol undiluted 1
- Reticular veins (1-3 mm diameter): Use 1% polidocanol undiluted 1
- Larger varicose veins (>3 mm, including saphenous veins): Use 3% polidocanol undiluted 2, 3, 4, 5
The 3% concentration is specifically formulated for treating larger vessels and should be used as-is, not diluted. This higher concentration is necessary to achieve adequate endothelial damage and vessel occlusion in larger diameter veins 4, 5.
Volume and Administration Guidelines for 3% Polidocanol
When using 3% polidocanol:
- Volume per injection: 0.1-0.3 mL per individual injection site 1
- Maximum volume per session: 10 mL total 1
- Needle size: 26- or 30-gauge, inserted tangentially 1
- Injection technique: Slow injection with gentle pressure to prevent vein rupture 1
For extensive varicosities requiring more than 10 mL, schedule repeat treatment sessions separated by 1-2 weeks 1.
Foam Preparation (Not Dilution)
The evidence distinguishes between dilution and foam preparation. 3% polidocanol can be converted to foam using the Double Syringe System (DSS) method, but this is aeration, not dilution—the concentration remains 3%. 5
Foam sclerotherapy with 3% polidocanol demonstrates:
- 84% elimination of reflux in great saphenous veins versus 40% with liquid 5
- 80.1% occlusion rate at 1 year with 3% foam versus 69.5% with 1% foam 4
- Superior cosmetic outcomes compared to lower concentrations 4
Critical Safety Considerations
Do not exceed recommended volumes or concentrations. The evidence shows:
- Volumes <0.5 mL of 3% polidocanol do not cause cutaneous necrosis even with extravasation 6
- Systemic doses of 2% polidocanol (0.5 mL) caused pulmonary vascular damage in animal studies 7
- Maximum 10 mL per session prevents systemic complications 1
Post-treatment compression is mandatory: 5-7 days for reticular veins, longer for extensive varicosities using gradient compression stockings 1. This reduces deep vein thrombosis risk.
Common Pitfall to Avoid
The most critical error is attempting to dilute 3% polidocanol thinking it's "too strong." The 3% concentration exists precisely because larger veins require higher sclerosant strength to achieve occlusion 4, 5. Diluting it reduces efficacy and increases treatment failure rates. If concerned about vessel size, select the appropriate pre-formulated concentration (0.5%, 1%, or 3%) rather than diluting 8.
For veins >3 mm diameter, particularly the great saphenous vein, 3% polidocanol foam achieves comparable results to thermal ablation with lower complication rates 8, 9.